| Bioactivity | Cap-dependent endonuclease-IN-15 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-15 inhibits the replication of influenza virus. Cap-dependent endonuclease-IN-15 has the potential for the research of viral infections caused by influenza viruses (extracted from patent CN113226327A, compound c-1)[1]. |
| Name | Cap-dependent endonuclease-IN-15 |
| CAS | 2581298-44-2 |
| Formula | C27H23F2N3O7Se |
| Molar Mass | 618.44 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Xiaolin Hao, et al. Compounds useful in the treatment of influenza virus infection. Patent CN113226327A. |
Cap-dependent endonuclease-IN-15
CAS: 2581298-44-2 F: C27H23F2N3O7Se W: 618.44
Cap-dependent endonuclease-IN-15 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-I
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.